These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 20799012

  • 1. Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors.
    Moon MJ, Kim HY, Kim SG, Park J, Choi DS, Hwang JI, Seong JY.
    Mol Cells; 2010 Aug; 30(2):149-54. PubMed ID: 20799012
    [Abstract] [Full Text] [Related]

  • 2. Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation.
    Moon MJ, Kim HY, Park S, Kim DK, Cho EB, Park CR, You DJ, Hwang JI, Kim K, Choe H, Seong JY.
    J Biol Chem; 2012 Feb 03; 287(6):3873-84. PubMed ID: 22105074
    [Abstract] [Full Text] [Related]

  • 3. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A, Hansotia T, Longuet C, Seino Y, Drucker DJ.
    Gastroenterology; 2009 Dec 03; 137(6):2146-57. PubMed ID: 19766644
    [Abstract] [Full Text] [Related]

  • 4. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.
    Al-Zamel N, Al-Sabah S, Luqmani Y, Adi L, Chacko S, Schneider TD, Krasel C.
    Int J Mol Sci; 2019 Jul 19; 20(14):. PubMed ID: 31330984
    [Abstract] [Full Text] [Related]

  • 5. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH, Inoue T, Higashiyama M, Guth PH, Engel E, Kaunitz JD, Akiba Y.
    J Pharmacol Exp Ther; 2011 Nov 19; 339(2):464-73. PubMed ID: 21846840
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
    Mroz PA, Finan B, Gelfanov V, Yang B, Tschöp MH, DiMarchi RD, Perez-Tilve D.
    Mol Metab; 2019 Feb 19; 20():51-62. PubMed ID: 30578168
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells.
    Al-Zaid B, Chacko S, Ezeamuzie CI, Bünemann M, Krasel C, Karimian T, Lanzerstorfer P, Al-Sabah S.
    Pharmacol Res Perspect; 2022 Oct 19; 10(5):e01013. PubMed ID: 36177761
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
    Yuliantie E, Darbalaei S, Dai A, Zhao P, Yang D, Sexton PM, Wang MW, Wootten D.
    Biochem Pharmacol; 2020 Jul 19; 177():114001. PubMed ID: 32360365
    [Abstract] [Full Text] [Related]

  • 10. The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.
    Al-Sabah S, Al-Fulaij M, Shaaban G, Ahmed HA, Mann RJ, Donnelly D, Bünemann M, Krasel C.
    PLoS One; 2014 Jul 19; 9(9):e106890. PubMed ID: 25191754
    [Abstract] [Full Text] [Related]

  • 11. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F.
    Diabetes; 1996 Feb 19; 45(2):257-61. PubMed ID: 8549871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand.
    Yaqub T, Tikhonova IG, Lättig J, Magnan R, Laval M, Escrieut C, Boulègue C, Hewage C, Fourmy D.
    Mol Pharmacol; 2010 Apr 19; 77(4):547-58. PubMed ID: 20061446
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW, Wheeler MB, Xue J, Gyomorey S, Nian C, Pederson RA, McIntosh CH.
    Endocrinology; 1997 Jun 19; 138(6):2640-3. PubMed ID: 9165060
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. GLP-1 and GIP receptor signaling in beta cells - A review of receptor interactions and co-stimulation.
    Mayendraraj A, Rosenkilde MM, Gasbjerg LS.
    Peptides; 2022 May 19; 151():170749. PubMed ID: 35065096
    [Abstract] [Full Text] [Related]

  • 19. Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.
    Gabe MBN, van der Velden WJC, Smit FX, Gasbjerg LS, Rosenkilde MM.
    Peptides; 2020 Mar 19; 125():170224. PubMed ID: 31809770
    [Abstract] [Full Text] [Related]

  • 20. Structural basis for ligand recognition of incretin receptors.
    Underwood CR, Parthier C, Reedtz-Runge S.
    Vitam Horm; 2010 Mar 19; 84():251-78. PubMed ID: 21094903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.